[HTML][HTML] Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10

J Wang, L Xie, C Yang, C Ren, K Zhou… - Frontiers in cellular …, 2015 - frontiersin.org
J Wang, L Xie, C Yang, C Ren, K Zhou, B Wang, Z Zhang, Y Wang, K Jin, GY Yang
Frontiers in cellular neuroscience, 2015frontiersin.org
Recent studies have demonstrated that the depletion of Regulatory T cells (Tregs) inhibits
neural progenitor cell migration after brain ischemia. However, whether Tregs affect neural
stem/progenitor cell proliferation is unclear. We explored the effect of Tregs on neurogenesis
in the subventricular zone (SVZ) after ischemia. Tregs were isolated and activated in vitro.
Adult male C57BL/6 mice underwent 60 min transient middle cerebral artery occlusion
(tMCAO). Then Tregs (1× 105) were injected into the left lateral ventricle (LV) of normal and …
Recent studies have demonstrated that the depletion of Regulatory T cells (Tregs) inhibits neural progenitor cell migration after brain ischemia. However, whether Tregs affect neural stem/progenitor cell proliferation is unclear. We explored the effect of Tregs on neurogenesis in the subventricular zone (SVZ) after ischemia. Tregs were isolated and activated in vitro. Adult male C57BL/6 mice underwent 60 min transient middle cerebral artery occlusion (tMCAO). Then Tregs (1 × 105) were injected into the left lateral ventricle (LV) of normal and ischemic mouse brain. Neurogenesis was determined by immunostaining. The mechanism was examined by inhibiting interleukin 10 (IL-10) and transforming growth factor (TGF-β) signaling. We found that the number of BrdU+ cells in the SVZ was significantly increased in the activated Tregs-treated mice. Double immunostaining showed that these BrdU+ cells expressed Mash1. Blocking IL-10 reduced the number of Mash1+/BrdU+ cells, but increased the amount of GFAP+/BrdU+ cells. Here, we conclude that activated Tregs enhanced neural stem cell (NSC) proliferation in the SVZ of normal and ischemic mice; blockage of IL-10 abolished Tregs-mediated NSC proliferation in vivo and in vitro. Our results suggest that activated Tregs promoted NSC proliferation via IL-10, which provides a new therapeutic approach for ischemic stroke.
Frontiers